Using a ratio of CD8+ T-cells per monoclonal, malignant B-cell in CLL blood samples, higher relative numbers of CD8+ T-cells correlated with better OS [72], suggesting that CD8+ T-cells might participate in leukemia control. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.